A 12-month prospective trial of inject and extend regimen for ranibizumab treatment of age-related macular degeneration.
Retina. 2013 Jul-Aug;33(7):1351-8. doi: 10.1097/IAE.0b013e3182831265.
Retina. 2013.
PMID: 23538578
Clinical Trial.